Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
Luca Magnani(Imperial College London), Mathieu Lupien(Ontario Institute for Cancer Research), Balázs Győrffy(Semmelweis University), Anne Mirabella(Dartmouth College), Tian‐Li Wang(Sichuan University), Alexander Stoeck(Boston Biomedical Research Institute), Xiaoyang Zhang(University of Utah), András Lánczky(Semmelweis University)
Cited by 185
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
|PLoS ONE|2013|1.9k
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
|Science|2017|1.6k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k